Related Experiment Video
Updated: Jun 10, 2026
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Potential use of RNA interference in cancer therapy
Connor Phalon1, Donald D Rao, John Nemunaitis
1Gradalis, Inc., Dallas, TX, USA.
Abstract:
RNA interference (RNAi) is an evolutionary conserved mechanism for specific gene silencing. This mechanism has great potential for use in targeted cancer therapy. Understanding the RNAi mechanism has led to the development of several novel RNAi-based therapeutic approaches currently in the early phases of clinical trials. It remains difficult to effectively deliver the nucleic acids required in vivo to initiate RNAi, and intense effort is under way in developing effective and targeted systemic delivery systems for RNAi. Description of in vivo delivery systems is not the focus of this review. In this review, we cover the rationale for pursuing personalised cancer therapy with RNAi, briefly review the mechanism of each major RNAi therapeutic technique, summarise and sample recent results with animal models applying RNAi for cancer, and provide an update on current clinical trials with RNAi-based therapeutic agents for cancer therapy. RNAi-based cancer therapy is still in its infancy, and there are numerous obstacles and issues that need to be resolved before its application in personalised therapy focusing on patient-cancer-specific targets can become standard cancer treatment, either alone or in combination with other treatments.
Insights
RNA interference (RNAi) offers promising targeted cancer therapy by silencing specific genes. While early clinical trials show potential, effective in vivo delivery remains a challenge for personalized cancer treatment.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- RNA interference (RNAi) is a natural gene silencing mechanism with therapeutic potential.
- Targeted cancer therapy using RNAi is an emerging field with novel approaches.
- Effective in vivo delivery of RNAi agents is a significant hurdle.
Purpose of the Study:
- To review the rationale for personalized RNAi cancer therapy.
- To briefly explain major RNAi therapeutic techniques.
- To update on RNAi cancer therapy clinical trials and animal model results.
Main Methods:
- Literature review of RNAi mechanisms and applications in cancer.
- Summary of recent findings from animal models.
- Update on ongoing clinical trials for RNAi cancer therapeutics.
Main Results:
- RNAi-based cancer therapy is in early development stages.
- Various RNAi techniques are being explored for cancer treatment.
- Animal studies show promise, but clinical translation faces challenges.
Conclusions:
- RNAi holds significant promise for personalized cancer therapy.
- Overcoming delivery challenges is crucial for clinical success.
- Further research is needed to establish RNAi as a standard cancer treatment.
Related Concept Videos
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:22MicroRNAs
01:22MicroRNAs